Strategic Partnerships

CV Therapeutics has evolved from an innovative research and development company, with a pipeline based on cutting-edge science, into a fully integrated biopharmaceutical company with a sales force targeting cardiology specialists. We thrive in a culture of discovery science that seeks new solutions for the unmet medical needs of patients, concentrating our internal research primarily on cardiovascular therapeutic areas and small molecule products. Through our efforts, we believe we have documented success developing and commercializing products for the benefit of patients.

CV Therapeutic’s partnering track record illustrates our experience in integrating partnership to expand our product pipeline and enhance the company’s overall growth. Our partnership strategy is to create alliances that synergize common goals and resources in a results-driven manner. We believe strong collaborations comprised of dedicated efforts and mutual goals can contribute significantly to long-term growth for both parties.

Our partnering approach includes:

• securing additional products for launch
• embracing co-promotion alliances
• expanding our R&D portfolio through partnering opportunities
• collaborating with innovative partners on early preclinical programs
• exploring out-licensing opportunities
• - for indications outside of the cardiovascular area
  - in territories outside of North America
• enhancing R&D efforts with value-adding technologies

By collaborating with partners, using combined resources wisely, and taking advantage of the strengths and expertise of talented professionals, we hope to improve the cardiovascular outlook for the many patients who continue to suffer from debilitating conditions.
 
Interested potential partners may forward their proposals for success to:

CV Therapeutics
Attn: Business Development Dept
3172 Porter Drive
Palo Alto, CA 94304

Or please contact us in the following ways:

• Phone: (650) 384-8627
• Email at partnerships@cvt.com